InfuSystem Holdings INFU
NYSE INFU
$12.18 -0.01 (-0.08%)
At close: Aug 20, 2026 · 2:18 PM UTC

InfuSystem Holdings (INFU) Other Non-Current Assets (2010 - 2026)

InfuSystem Holdings' (INFU) quarterly Other Non-Current Assets came in at $1.6 million in Q1 2026, up 175.71% YoY from $597000.0 in Q1 2025, and down 1.91% on a QoQ basis from $1.7 million in Q4 2025.

InfuSystem Holdings (INFU) Other Non-Current Assets (2010 - 2026) Analysis & Trends

InfuSystem Holdings (INFU) has 17 years of Other Non-Current Assets data on file, last reported at $1.6 million in Q1 2026.

  • Quarterly Other Non-Current Assets rose 175.71% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 175.71% YoY) and the FY2025 annual result came in at $1.7 million, up 91.12% from the prior year.
  • Other Non-Current Assets slipped to $1.6 million in Q1 2026, from $1.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.2 million in Q3 2022 to a low of $80000.0 in Q4 2022.
  • A 5-year average of $1.2 million and a median of $1.3 million in 2024 frame the typical range for Other Non-Current Assets.
  • The widest YoY moves for Other Non-Current Assets: up 1876.25% in 2023, down 69.2% in 2023.
  • Tracing INFU's Other Non-Current Assets over 5 years: stood at $80000.0 in 2022, then surged by 1876.25% to $1.6 million in 2023, then sank by 44.47% to $878000.0 in 2024, then surged by 91.12% to $1.7 million in 2025, then fell by 1.91% to $1.6 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.6 million (Q1 2026), $1.7 million (Q4 2025), and $499000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn -
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn 3.23 Bn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 4.15 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn 616.40 Mn
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn 273.70 Mn
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn 2.25 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 148.78 Mn
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn 215.10 Mn
10 InfuSystem Holdings 244.47 Mn 243.50 Mn 21.41 Mn 1.52 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.52 Mn
Mar 31, 2026 1.65 Mn
Dec 31, 2025 1.68 Mn
Sep 30, 2025 499,000.00
Jun 30, 2025 432,000.00
Mar 31, 2025 597,000.00
Dec 31, 2024 878,000.00
Sep 30, 2024 1.01 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 1.59 Mn
Dec 31, 2023 1.58 Mn
Sep 30, 2023 1.76 Mn
Jun 30, 2023 1.22 Mn
Mar 31, 2023 425,000.00
Dec 31, 2022 80,000.00
Sep 30, 2022 2.18 Mn
Jun 30, 2022 1.56 Mn
Mar 31, 2022 1.38 Mn
Dec 31, 2021 116,000.00
Sep 30, 2021 207,000.00